AI Summary
We reviewed 14 live results for scig and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Scig and Immunoglobulin.
Comparison Table
Recommended
HyQvia
Source: Takeda Pharmaceuticals
Description
HyQvia is a facilitated subcutaneous immunoglobulin (SCIG) 10% liquid that uses recombinant human hyaluronidase to allow for larger infusion volumes. It is indicated for PI and CIDP, often requiring only one infusion every 3 to 4 weeks.
Best for
infrequent dosing, facilitated SCIG, PI and CIDP and fewer needle sticks
View Details
Rating
Hizentra
Source: CSL Behring
Description
Hizentra is a 20% liquid subcutaneous immunoglobulin (SCIG) high-concentration formula designed for self-administration. It is indicated for Primary Humoral Immunodeficiency (PI) and as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Its high concentration allows for lower infusion volumes compared to 10% products.
Best for
self-administration, home-based therapy, CIDP maintenance and high-concentration IgG
View Details
Rating
Cutaquig
Source: Octapharma
Description
Cutaquig is a 16.5% liquid SCIG indicated for PI in adults and pediatric patients aged 2 and older. It supports flexible infusion regimens ranging from daily to every other week.
Best for
flexible infusion schedules, pediatric PI patients and SCIG administration
View Details
Rating
| Compare | HyQvia | Hizentra | Cutaquig |
|---|---|---|---|
| Source | Takeda Pharmaceuticals | CSL Behring | Octapharma |
| Description | HyQvia is a facilitated subcutaneous immunoglobulin (SCIG) 10% liquid that uses recombinant human hyaluronidase to allow for larger infusion volumes. It is indicated for PI and CIDP, often requiring only one infusion every 3 to 4 weeks. | Hizentra is a 20% liquid subcutaneous immunoglobulin (SCIG) high-concentration formula designed for self-administration. It is indicated for Primary Humoral Immunodeficiency (PI) and as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Its high concentration allows for lower infusion volumes compared to 10% products. | Cutaquig is a 16.5% liquid SCIG indicated for PI in adults and pediatric patients aged 2 and older. It supports flexible infusion regimens ranging from daily to every other week. |
| Best for | infrequent dosing, facilitated SCIG, PI and CIDP and fewer needle sticks | self-administration, home-based therapy, CIDP maintenance and high-concentration IgG | flexible infusion schedules, pediatric PI patients and SCIG administration |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"HyQvia from Takeda Pharmaceuticals."
I picked this because HyQvia is ideal for patients who want the convenience of subcutaneous delivery but with the infrequent dosing schedule of IV therapy.
Share this search
Related Finds